Literature DB >> 4437730

The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.

A R Green, D G Grahame-Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4437730     DOI： 10.1016/0028-3908(74)90086-0

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN： 0028-3908            Impact factor:   5.250


× No keyword cloud information.
  30 in total

1.  Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome".

Authors:  E K Silbergeld; R E Hruska
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

2.  Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: relevance to the mechanism of the antidepressive effect of electroconvulsive therapy.

Authors:  D W Costain; A R Green; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

Review 3.  Serotonin syndrome and drug combinations: focus on MAOI and RIMA.

Authors:  S E Hilton; H Maradit; H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

4.  The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats.

Authors:  C A Marsden; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1978-04-14       Impact factor: 4.530

5.  Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine.

Authors:  A R Green; D J Heal; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

6.  Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats.

Authors:  D J Heal; A R Green; M R Bloomfield; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

7.  Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.

Authors:  A R Green; B D Mitchell; A F Tordoff; M B Youdim
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

8.  Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.

Authors:  J P Evans; D G Grahame-Smith; A R Green; A F Tordoff
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

9.  Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated?

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  Pharmacoprophylaxis of alcohol dependence: Review and update Part I: Pharmacology.

Authors:  Sandeep Grover; Gaurav Bhateja; Debasish Basu
Journal:  Indian J Psychiatry       Date:  2007-01       Impact factor: 1.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.